Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Efficacy and Safety Comparison of Drug Therapies for Lower-Risk Myelodysplastic Syndromes: A Systematic Review and Network Meta-Analysis

  • By

  • Haixia Zhang

  • Jiaqiang Hu

  • Yaxi Jiang

  • Lihua Deng

  • Song Liu

  • June 16, 2026

Share

Original Source(s)

Comparative efficacy and safety of pharmacological treatments for lower-risk myelodysplastic syndromes: a Systematic Review and network meta-analysis

  • by Haixia Zhang, Jiaqiang Hu, Yaxi Jiang, Lihua Deng, Song Liu

  • June 16, 2026

Related Content

Moving Cancer Survivorship Into Routine Care—Why Are We Still Not Ready for Change?

Correction: γδ T cells in immunotherapies for B-cell malignancies

Correction: Review and analysis of clinical trials of selective RET inhibitors for the treatment of thyroid cancer